Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: A multicenter experience

Nephron - Clinical Practice

Volumn 117, Issue 3, 2011, Pages

  Kazancioglu, Rumeyza ^a,m   Ecder, Tevfik ^b   Altintepe, Lutfullah ^f   Altiparmak, Mehmet Riza ^c   Tuglular, Serhan ^d   Uyanik, Abdullah ^g   Cavdar, Caner ^h   Ecder, Sabahat Alisir ^e   Tokgoz, Bulent ⁱ   Duman, Neval ^j   Duzova, Ali ^l   Cetinkaya, Ramazan ^k  

^a Haseki Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Cerrahpa a Faculty of Medicine   (Turkey)

^d MARMARA UNIVERSITY   (Turkey)

^e GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g ATATURK UNIVERSITY   (Turkey)

^h DOKUZ EYLUL UNIVERSITY   (Turkey)

ⁱ ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^j ANKARA UNIVERSITY   (Turkey)

^k ANTALYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^l HACETTEPE UNIVERSITY   (Turkey)

^m HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

more..

Author keywords

Autosomal dominant polycystic kidney disease; Demographics; Hypertension; Urinary tract infection; Urolithiasis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD PRESSURE; CIGARETTE SMOKING; CLINICAL TRIAL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; GENDER; HEMATURIA; HEMODIALYSIS; HERNIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; MULTICENTER STUDY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; URINARY TRACT INFECTION; UROLITHIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RISK FACTORS; TURKEY; YOUNG ADULT;

EID: 77956572308     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320745     Document Type: Article

References (26)

1. Schrier RW: Optimal care of autosomal dominant polycystic kidney disease patients. Nephrology 2006;11:124-130.
2. Sessa A, Righetti M, Battini G: Autosomal recessive and dominant polycystic kidney diseases. Minerva Urol Nefrol 2004;56:329-338.
3. Ecder T, Fick-Brosnahan G, Schrier RW: Polycystic kidney disease; in Schrier RW (ed): Diseases of the Kidney and Urinary Tract. Philadelphia, Lippincott Williams and Wilkins, 2007, pp 502-539.
4. Pei Y: Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med 2003;26:252-258. (Pubitemid 37463935)
5. Schrier RW, McFann K, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003;63:678-685. (Pubitemid 36126815)
6. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009;76:149-168.
7. Fall PJ, Prisant LM: Polycystic kidney disease. J Clin Hypertens 2005;7:617-619, 625.
8. Taylor M, Johnson AM, Tison M, Fain P, Schrier R: Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications. Am J Kidney Dis 2005;46:415-423. (Pubitemid 41208176)
9. Perrone RD, Kausz AT, Chavers BM, Weinhandl ED, Collins AJ: Incidence of autosomal dominant polycystic kidney disease (ADPKD) among ESRD patients in the United States, 1991-2003. J Am Soc Nephrol 2005;16:358A.
10. Chapman AB: Cystic disease in women: clinical characteristics and medical management. Adv Ren Replace Ther 2003;10:24-30. (Pubitemid 36278327)
11. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D: Polycystic kidney disease re-evaluated: a population-based study. Q J Med 1991;79:477-485.
12. Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, Schrier RW: Progress in blood pressure control in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;36:266-271. (Pubitemid 30485834)
13. Orth SR: Smoking, a renal risk factor. Nephron 2000;86:12-26.
14. Orth SR, Stockman A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926-931. (Pubitemid 28397411)
15. Memili VK, Kutlu Ç, Sar F, Kazancioǧlu R: Demographic analysis of polycystic kidney disease patients: a single center experience. BANTAO J 2007;5:6-9.
16. Terada N, Arai Y, Kinukawa N, Yoshimura K, Terai A: Risk factors for renal cysts. BJU Int 2004;93:1300-1302. (Pubitemid 38823957)
17. Martinez-Vea A, Bardaj A, Gutierrez C, Garca C, Peralta C, Marcas L, Oliver JA: Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis 2004;44:216-223. (Pubitemid 38962549)
18. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995;5:2048-2056.
19. Schrier RW, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomaldominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol 2002;13:1733-1739. (Pubitemid 34700597)
20. Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1999;14:1113-1116. (Pubitemid 29209293)
21. Gabow PA, Duley I, Johnson AM: Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992;20:140-143.
22. Gibson P, Watson ML: Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant 1998;13:2455-2457. (Pubitemid 28445847)
23. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Sutherland S: Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years. Am J Kidney Dis 1990;15:237-243. (Pubitemid 20151184)
24. Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsed R, Johnson AM, Gabow P: Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;36:53-57. (Pubitemid 30432564)
25. Torres VE, Wilson DM, Hattery RR, Segura JW: Renal stone disease in autosomal polycystic kidney disease. Am J Kidney Dis 1993;22:513-519. (Pubitemid 23308959)
26. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992;41:1311-1319.